Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulinoma; Pancreas”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Not applicableLooking for participantsNCT00001276
What this trial is testing

Diagnosing and Treating Low Blood Sugar Levels

Who this might be right for
HypoglycemiaInsulinoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1,500
Not applicableStudy completedNCT02127541
What this trial is testing

New Imaging Procedure for the Localisation of Insulinoma

Who this might be right for
Endogenous Hyperinsulinaemic Hypoglycaemia
University Hospital, Basel, Switzerland 52
Not applicableStudy completedNCT04741152
What this trial is testing

Blinded Resection in Case of the Pancreatic Insulinoma

Who this might be right for
Insulinoma; Pancreas
Vishnevsky Center of Surgery 197
Early research (Phase 1)Looking for participantsNCT02021604
What this trial is testing

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Who this might be right for
Congenital HyperinsulinismInsulinoma
Cook Children's Health Care System 250
Not applicableActive Not RecruitingNCT03583528
What this trial is testing

DOTATOC PET/CT for Imaging NET Patients

Who this might be right for
Neuroendocrine TumorsInsulinomaGastrinoma+13 more
British Columbia Cancer Agency 800
Testing effectiveness (Phase 2)Study completedNCT00131911
What this trial is testing

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+7 more
National Cancer Institute (NCI) 93
Testing effectiveness (Phase 2)WithdrawnNCT02108782
What this trial is testing

Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+3 more
Academic and Community Cancer Research United
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)WithdrawnNCT00227773
What this trial is testing

Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell Carcinoma
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT00937079
What this trial is testing

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

Who this might be right for
HyperinsulinismHypoglycemiaInsulinoma
University Hospital, Basel, Switzerland 30
Testing effectiveness (Phase 2)Ended earlyNCT01056601
What this trial is testing

Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy

Who this might be right for
Pancreatic Cancer
Masonic Cancer Center, University of Minnesota 7
Not applicableUnknownNCT05523778
What this trial is testing

A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct

Who this might be right for
Insulinoma
Peking Union Medical College Hospital 78
Testing effectiveness (Phase 2)Ended earlyNCT02273752
What this trial is testing

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more
Emory University 2
Not applicableNo Longer AvailableNCT02431715
What this trial is testing

18F-FDOPA PET in Neuroendocrine Tumours

Who this might be right for
Thyroid Cancer, MedullaryCarcinoid TumorPheochromocytoma+3 more
British Columbia Cancer Agency
Not applicableUnknownNCT02121366
What this trial is testing

EUS-guided Ethanol Ablation of an Insulinoma

Who this might be right for
Insulinoma
Guangxi Medical University 50
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00075439
What this trial is testing

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
National Cancer Institute (NCI) 90
Not applicableAvailableNCT07262970
What this trial is testing

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Who this might be right for
Tumor-associated Hyperinsulinism (Tumor HI)
Rezolute
Testing effectiveness (Phase 2)Study completedNCT01525082
What this trial is testing

Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
Shaheen Shagufta 20
Load More Results